Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 8/20 | 0.36 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
| ▸ | ITGAV | P06756 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12673964 | 1.00 | PPARG (0.36) | PPARGPLA2G2CITGB3ITGAVHSP90AA1 | |
| SCHEMBL13880584 | 0.94 | CXCR2 (0.36) | PPARGPLA2G2CHSP90AA1EPHX2CXCR2 | |
| SCHEMBL13892164 | 0.91 | FAAH (0.38) | EPHX2FAAH | |
| SCHEMBL13113625 | 0.90 | CASP2 (0.40) | EPHX2FAAH | |
| SCHEMBL16093010 | 0.90 | CASP2 (0.40) | EPHX2FAAH | |
| SCHEMBL13880602 | 0.90 | MTNR1A (0.33) | PLA2G2CCXCR2 | |
| SCHEMBL12809270 | 0.90 | FAAH (0.34) | PPARGEPHX2FAAH | |
| SCHEMBL1688321 | 0.90 | FAAH (0.38) | PPARGITGB3ITGAVFAAH | |
| SCHEMBL12641022 | 0.89 | PPARG (0.30) | PPARG | |
| SCHEMBL13694066 | 0.89 | PPARG (0.30) | PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120088716-A1 | Polypeptide Protracting Tags | NOVO NORDISK A/S (DK) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088716-A1 | Polypeptide Protracting Tags | VIP, FGB, NPPA | PPARG 1969/4885PLA2G2C 1461/4885ITGB3 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.